000 01259 a2200301 4500
005 20250518055512.0
264 0 _c20200211
008 202002s 0 0 eng d
022 _a1530-891X
024 7 _a10.4158/EP-2019-0244
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAl Mushref, Mazen
245 0 0 _aTHYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
_h[electronic resource]
260 _bEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
_cJan 2020
300 _a36-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aHumans
650 0 4 _aMelanoma
650 0 4 _aNivolumab
650 0 4 _aPrognosis
650 0 4 _aRetrospective Studies
700 1 _aGuido, Paul A
700 1 _aCollichio, Frances A
700 1 _aMoore, Dominic T
700 1 _aClemmons, David R
773 0 _tEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
_gvol. 26
_gno. 1
_gp. 36-42
856 4 0 _uhttps://doi.org/10.4158/EP-2019-0244
_zAvailable from publisher's website
999 _c30053354
_d30053354